Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Abilify (aripiprazole) Digital Medicine for Treatment of Schizophrenia

Drug (Brand / Generic)

Abilify (aripiprazole)

Developed by

Otsuka Pharmaceutical / Proteus Digital Health

Therapy Class

Atypical antipsychotic

Product Description

Dopamine partial agonist

Current Indication

Schizophrenia

Market Sector

CNS

Development Status

Approved in the US, sensor-embedded version under review by the FDA
Expand

Go Top